IRIS
MOIA, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.147
NA - Nord America 1.640
AS - Asia 1.448
SA - Sud America 206
AF - Africa 86
OC - Oceania 4
Totale 5.531
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.555
RU - Federazione Russa 728
SG - Singapore 515
IT - Italia 422
IE - Irlanda 277
CN - Cina 254
HK - Hong Kong 231
DE - Germania 196
VN - Vietnam 191
BR - Brasile 172
SE - Svezia 131
FR - Francia 123
GB - Regno Unito 78
IN - India 76
CA - Canada 49
BJ - Benin 40
UA - Ucraina 39
KR - Corea 38
FI - Finlandia 37
MX - Messico 31
BD - Bangladesh 27
PL - Polonia 27
ID - Indonesia 20
JP - Giappone 19
TR - Turchia 18
ZA - Sudafrica 17
AT - Austria 14
ES - Italia 13
LT - Lituania 13
NL - Olanda 13
IQ - Iraq 12
AR - Argentina 11
EC - Ecuador 8
ET - Etiopia 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
IR - Iran 6
BE - Belgio 5
CO - Colombia 5
EG - Egitto 5
PH - Filippine 5
AU - Australia 4
KE - Kenya 4
PE - Perù 4
PK - Pakistan 4
UZ - Uzbekistan 4
AL - Albania 3
DK - Danimarca 3
HR - Croazia 3
NG - Nigeria 3
SY - Repubblica araba siriana 3
VE - Venezuela 3
AO - Angola 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
RS - Serbia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
Totale 5.531
Salva come PNG Salva come JPEG
Città #
San Jose 302
Dublin 275
Hong Kong 229
Singapore 218
Ashburn 170
Beijing 103
Los Angeles 78
Lauterbourg 68
Chandler 61
Moscow 61
Novara 59
Jacksonville 57
Ho Chi Minh City 53
Boardman 47
Hanoi 46
Munich 45
Cotonou 40
New York 37
Seoul 34
Vercelli 32
Buffalo 31
Lawrence 31
Piemonte 31
Princeton 31
Helsinki 30
Milan 27
Frankfurt am Main 26
Orem 26
Santa Clara 24
São Paulo 24
Bremen 23
Warsaw 23
Falkenstein 21
Turin 21
Dallas 20
Mexico City 19
Chennai 18
Grafing 18
Council Bluffs 17
London 17
Tokyo 16
Toronto 16
Wilmington 16
Nuremberg 15
Poplar 15
Denver 14
Montreal 14
Johannesburg 13
Podenzano 13
Atlanta 12
Brooklyn 12
Houston 12
San Mateo 12
Hillsboro 11
Belo Horizonte 10
Boston 10
Chicago 10
Mumbai 10
Ankara 9
Phoenix 9
Addis Ababa 8
Cassano Magnago 8
Haiphong 8
Manchester 8
Redondo Beach 8
Roseto degli Abruzzi 8
Amsterdam 7
Augusta 7
City of London 7
Da Nang 7
Ottawa 7
Stockholm 7
Ann Arbor 6
Bexley 6
Brno 6
Genoa 6
Guangzhou 6
Hangzhou 6
Menlo Park 6
Rome 6
Roubaix 6
Strasbourg 6
Turku 6
West Jordan 6
Berlin 5
Brussels 5
Dalian 5
Gunzenhausen 5
Jakarta 5
Poços de Caldas 5
Rimini 5
Rio de Janeiro 5
Seattle 5
Tianjin 5
Tornaco 5
Barnet 4
Brasília 4
Charlotte 4
Curitiba 4
Hải Dương 4
Totale 2.979
Salva come PNG Salva come JPEG
Nome #
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 142
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 135
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 129
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 129
Targeting p53 in chronic lymphocytic leukemia 121
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 116
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 114
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 113
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 112
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity 112
Precision medicine management of chronic lymphocytic leukemia 109
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 108
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 106
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 105
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 103
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations 101
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 100
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome 96
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 95
Druggable Molecular Pathways in Chronic Lymphocytic Leukemia 95
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 94
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient 94
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 91
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 89
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications 88
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 86
High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias 85
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial 84
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 84
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 84
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib 83
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia 83
Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination 83
Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia 82
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 82
High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy 81
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 80
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab 79
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia 79
Liquid biopsy in hematological malignancies: current and future applications 78
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment 76
Prognostication in chronic lymphocytic leukemia 75
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY 70
Reply to Aron P. Kater et al 68
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia 66
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 64
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation 63
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY 62
null 62
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY 62
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma 61
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 61
HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma 61
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 60
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL 58
Prevalence and clinical impact of clonal hematopoiesis of indeterminate potential (CHIP) in chronic lymphocytic leukemia and richter transformation 56
Updated revision of the British Society of Haematology guidelines for chronic lymphocytic leukaemia 54
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience 53
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study 50
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy 48
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands 47
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma 47
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA 39
Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside 38
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia 38
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report 37
Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy 35
Unraveling the Epigenetic Landscape of Mature B Cell Neoplasia: Mechanisms, Biomarkers, and Therapeutic Opportunities 33
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial 31
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL 27
Diagnostic Challenges in a Young Man with a Suspected Mast Cell Disorder, Dysplastic Bone Marrow Morphology, and a ZRSR2 Mutation 26
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms 25
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker 21
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation 18
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes 15
Totale 5.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 17 16 0
2021/2022228 2 4 10 9 19 3 23 3 5 23 60 67
2022/2023603 41 30 48 9 36 43 30 30 263 6 50 17
2023/2024344 27 28 31 11 41 11 46 4 1 17 36 91
2024/2025958 16 12 68 13 36 48 87 213 182 78 36 169
2025/20263.301 171 123 212 425 415 269 551 589 298 248 0 0
Totale 5.637